Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe
Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe to evaluate the anti-cancer drug candidate as ... Read More
Imperial College begins human trial of coronavirus vaccine candidate COVAC1
Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate, which has been developed using the new ... Read More
Merck completes acquisition of Austrian vaccine developer Themis Bioscience
Pharma giant Merck has wrapped up its previously announced acquisition of Austrian vaccine developer Themis Bioscience. The Austrian company is focused on developing vaccines and ... Read More
Lilly Covid drug trial : US pharma giant launches phase 3 trial of baricitinib
Lilly Covid drug trial : Eli Lilly and Company has enrolled the first patient in a phase 3 randomized, double-blind, placebo-controlled trial to assess the ... Read More
Sinovac Biotech CoronaVac COVID-19 vaccine candidate succeeds in phase 1/2 trial
Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive preliminary results by showing favorable immunogenicity and ... Read More
Intranasal COVID-19 vaccine : Intravacc, WBVR and Utrecht University join forces for vaccine development
Dutch vaccine maker Intravacc has forged a partnership with Wageningen Bioveterinary Research (WBVR) and Utrecht University in the Netherlands to develop an intranasal COVID-19 vaccine. ... Read More